The study of the chemical composition and the anti-inflammatory activity of dry extracts from large cranberry leaves
DOI:
https://doi.org/10.24959/nphj.23.106Keywords:
large cranberry; leaves; extract; biologically active substances; anti-inflammatory activityAbstract
Inflammation accompanies huge numbers of diseases. In case of inflammation, non-steroidal anti-inflammatory drugs are used, but they have a number of side effects and disadvantages. In turn, medicines based on the medicinal plant raw material that exhibit the anti-inflammatory activity, on the contrary, are underestimated and insufficiently
studied. An interesting object in this direction is large cranberry leaves of Ericaceae family.
Aim. To study the chemical composition and the anti-inflammatory activity of extracts from large cranberry leaves to establish the prospect of creating new drugs with the anti-inflammatory activity.
Materials and methods. The study objects were dry extracts from large cranberry (Oxycoccus macrocarpus (Ait.)) leaves. The chemical analysis of the extracts was studied by TLC and spectrophotometry methods. The anti-inflammatory activity of the extracts was studied on the model of carrageenan edema.
Results and discussion. Hyperoside and chlorogenic acid were identified in the extracts. In the dry extract from large cranberry leaves, the content of the total amount of derivatives of hydroxycinnamic compounds was 11.60 ± 0.05 %, and in the modified extract – 3.09 ± 0.05 %. The anti-exudative activity was more pronounced in the group of animals that received the cranberry extract with arginine in the dose of 100 mg/kg.
Conclusions. Identification and the quantification of biologically active substances in large cranberry leaves extracts have been carried out; their anti-inflammatory activity has been determined.
References
Gómez-Acebo I., Dierssen-Sotos T., Pedro. M. Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCCSpain study. BMC Public Health. 2018. Vol. 18. P. 1134. DOI: https://doi.org/10.1186/s12889-018-6019-z.
Taschina M., Moisa C., Lupitu A., Copolovici D. M., Copolovici L. Influence of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) on Photosynthetic Parameters and Secondary Metabolites of Plants from Fabaceae Family. Appl. Sci. 2022. Vol. 12. P. 6326. DOI: https://doi.org/10.3390/app12136326.
Колонтарев К. Б. Применение препаратов клюквы у больных с рецидивирующей мочевой инфекцией. Эффект. фармакотер. урол. и нефрол. 2013. № 3 (26). С. 42-46.
Vlasova I., Gontova T., Grytsyk L., Zhumashova G., Sayakova G., Boshkayeva A., Shanaida M., Kоshovyi О. Determination of standardization parameters of Oxycoccus macrocarpus (Ait.) pursh and Oxycoccus palustris Pers. Leaves. ScienceRise: Pharmaceutical Science. 2022. Vol. 3 (37). P. 48–57. DOI: http://doi.org/10.15587/2519-4852.2022.260352.
Кошовий О. М., Власова І. К., Брюханова Т. О., Красільнікова О. А., Кравченко Г. Б., Загайко А. Л., Комісаренко М. А. Спосіб одержання лікувально-профілактичного засобу з листя журавлини великоплодої для корекції інсулінорезистентних станів. Патент на корисну модель № 147975 Україна. № u202100821, заявл. 22.02.2021; опубл. 23.06.2021, бюл. № 25/2021.
Власова І. К., Кошовий О. М., Кухтенко О. С., Комісаренко М. А., Ільїна Т. В., Ковальова А. М. Визначення параметрів екстра-
кції біологічно активних речовиніз журавлини листя. Актуальні питання фармацевтичної і медичної науки та практики. 2022.
№ 15, т. 2 (39). С. 145-152.
Vlasova І. K., Koshovyi O. M. Standardization of dry extracts from large cranberry leaves. Journal of organic and pharmaceutical chemistry. 2022. Vol. 20 (3). P. 40-45.
Доклінічні дослідження лікарських засобів : метод. рек. / під ред. О. В. Стефанова. Київ : Авіцена, 2001. 527 с.
European Convention for the Protection of Vertebrate Animals Used for Experimental and other Scientific Purposes. Strasbourg, 18 March 1986. URL: https://zakon.rada.gov.ua/laws/show/994_137.
Procedure for Carrying out Experiments, Experiments on Animals by Scientific Institutions: Order of the Ministry of Education and Science, Youth and Sports of Ukraine № 249 dated 1 March 2012. URL: http://zakon.rada.gov.ua/laws/show/z0416-12.
Stremoukhov O., Koshovyi O., Komisarenko M. Phytochemical research and anti-inflammatory activity of the dry extracts from northern highbush blueberry leaves. ScienceRise: Pharmaceutical Science. 2021. Vol. 2. P. 40–48. DOI: https://doi.org/10.15587/2519-4852.2021.230288.
Myha M., Koshovyi O., Gamulya O., Ilina T., Borodina N., Vlasova I. Phytochemical study of Salvia grandiflora and Salvia officinalis leaves for establishing prospects for use in medical and pharmaceutical practice. ScienceRise: Pharmaceutical Science. 2020. Vol. 1 (23). P. 23-28. DOI: https://doi.org/10.15587/2519-4852.2020.197299.
Державна фармакопея України / Державне підприємство «Науковий фармакопейний центр якості лікарських засобів». 2-е вид. Харків: ДП «Науковий фармакопейний центр якості лікарських засобів», 2015. Т. 3. 732 с.
Koshovyi O., Granica S., Piwowarski J. P., Stremoukhov O., Kostenko Y., Kravchenko G., Krasilnikova O., Zagayko A. Highbush blueberry (Vaccinium corymbosum L.) leaves extract and its modified arginine preparation for the management of metabolic syndrome – chemical analysis and bioactivity in rat model. Nutrients. 2021, Vol. 13. P. 2870. DOI: https://doi.org/10.3390/nu13082870.
Koshovyi O., Romanenko Ye., Komissarenko A. The study of the phenolic composition of the dry extract of motherwort herb and its psychotropic activity. American Journal of Science and Technologies, “Princeton University Press”. 2016. Vol. 1 (21). P. 1055-1059.
Кошовий О. М. Дослідження фенольних сполук спиртового екстракту листя евкаліпта прутовидного. Фармаком. 2010. № 3. С. 27–31.
Ковальова A. M., Георгієвський Г. В., Ковальов В. M. Розробка метода стандартизації нового лікарського засобу піфламін. Фармаком. 2002. № 2. С. 92–97.
Хомич Н. М., Огоновський Р. З., Патерега І. П. Експериментальне дослідження антиексудативних властивостей препарату «Дексаметазон» та локальної гіпотермії за умов розвитку запалення, викликаного флогогеном карагенін. Актуальні проблеми сучасної медицини. 2014. № 14 (3). С. 270-273.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
